INTRODUCTION
Previously, we purified apolipoprotein A-II (apoA-II) from fetalcalf serum as a substance which inhibits the growth of the yeast Saccharomyces cere isiae. Purified apoA-II inhibits the growth of Escherichia coli more than that of yeasts [1] . ApoA-II is a protein component of high-density lipoprotein (HDL) and interacts with phospholipids through its amphipathic α-helix [2] . Human apoA-II, and especially its C-terminal domain [3, 4] , has a high affinity for lipids and is able to displace apolipoprotein A-I (apoA-I) from HDL [5] . The main function of lipoprotein is to transport lipids and lipid-soluble materials throughout the body. Additionally, human apoA-I and A-II have been shown to interact with many cellular systems, including spermatozoa, neutrophils, complements, placental tissue and viruses [6] [7] [8] [9] [10] . It is postulated that the amphipathic α-helix plays a central role for lipid binding and many biological functions mediated by apolipoproteins [11] .
Numerous antimicrobial proteins and peptides of various structures have been identified and characterized from many organisms, including bacteria, fungi, insects, amphibians, reptiles and mammals [12] . These proteins and peptides are believed to play important roles in innate immunity [13, 14] and many of them are studied to develop new therapeutic approaches for infectous diseases [15, 16] . Antimicrobial peptides possess various Abbreviations used : ApoA-I, apolipoprotein A-I ; ApoA-II, apolipoprotein A-II ; calcein, 2h,7hbis(carboxymethyl)aminomethylfluorescein ; CL, cardiolipin ; CFU, colony-forming unit ; HDL, high-density lipoprotein ; MLV, multilamellar vesicles ; Myr 2 GroPCho, L-dimyristoylglycerophosphocholine ; PC, phosphatidylcholine ; PE, L-phosphatidylethanolamine ; PG, L-phosphatidyl-DL-glycerol ; SUV, small unilamellar vesicles ; TFE, trifluoroethanol ; P/L, peptide/lipid. 1 To whom correspondence should be addressed (e-mail Ktsurugi!swallow.res.yamanashi-med.ac.jp).
Leu%*-Thr(', some proteins were released to the external medium, probably owing to membrane destabilization caused by the peptide. In electron micrographs of E. coli cells treated with peptide Leu%*-Thr(', transparent nucleoids and granulated cytoplasm were observed. Amino acid substitutions, Phe&#Phe&$ AlaAla (Phe&# ,&$ Ala) in peptide Leu%*-Thr(' caused the loss of antimicrobial activity against E. coli, although protein-releasing activity was retained. Electron micrographs of the cells treated with peptide Leu%*-Thr('(Phe&# ,&$ Ala) revealed morphological change only at the nucleoids. Therefore peptide Leu%*-Thr(' appears to primarily target the cytoplasm rather than the membrane of E. coli cells.
Key words : Antimicrobial peptide, apolipoprotein A-II, amphipathic helix, circular dichroism. structural characteristics [13, 17] , including amphipathic α-helices and β-sheets, and are usually cationic and membrane active. Many cationic antimicrobial peptides, such as cecropins and magainins, permeate the outer membrane of bacteria and form channels or pores in the cytoplasmic membrane [12, 16, 18] . The amphipathic helices in human apoA-I have been postulated to stabilize membrane bilayers [19, 20] . In contrast, Lambert et al. have demonstrated that residues 53-70 of human apoA-II form oblique-orientated helices at the lipid\water interface and induce membrane destabilization [21] . Therefore, the aim of the present study was to examine the structural features of apoA-II which induces antimicrobial activity and to determine the antimicrobial domain using synthetic peptides. We have shown that the peptide Leu%*-Thr(' was responsible for the anti-E. coli and lipid-binding activities of apoA-II. We have also shown that peptide Leu%*-Thr(' forms an amphipathic α-helix at its N-terminal region that is required for the activity.
EXPERIMENTAL Materials
Bovine apoA-II was isolated from fetal-calf serum as described previously [1] . -Phosphatidylethanolamine (PE), -phosphatidyl--glycerol (PG), cardiolipin (CL), -dimyristoylglycero- Figure 1 phosphocholine (Myr # GroPCho) and 2h,7h-bis(carboxymethyl)-aminomethylfluorescein (calcein) were purchased from Sigma.
Micro-organisms
Micro-organisms used in this study were Escherichia coli A.T.C.C. 25922 and Saccharomyces cere isiae A364A. Growth media consisted of YPD medium [1 % (w\v) yeast extract\2 % (w\v) peptone\2 % (w\v) glucose] for S. cere isiae and Luriabroth medium for E. coli [1] .
Synthetic peptides
The following synthetic peptides were used ( Figure 1 ) : peptides Glu"-Lys$!, Gly$"-Leu'!, Leu%*-Thr(' and Thr&)-Thr(' corresponding to the residues 1-30, 31-60, 49-76 and 58-76 of apoA-II respectively ; peptide Leu%*-Thr('(Phe&# ,&$ Ala) bearing the substitution Ala-Ala for Phe-Phe at positions 52 and 53 ; peptide Leu%*-Thr('(Lys&% ,&& Ser) with a substitution of Ser-Ser for Lys-Lys at positions 54 and 55. The six peptides were synthesized on resin with a model 433A automated peptide synthesizer (Perkin-Elmer Applied Biosystems Division, Foster, CA, U.S.A.), using the 9-fluorenylmethylcarbonyl (' Fmoc ') strategy. They were purified by reverse-phase HPLC using a C ") column with a linear gradient of 5-65 % solution B (0.075 % trifluoroacetic acid in acetonitrile) in solution A (0.1 % trifluoroacetic acid in water). The identity of each peptide was confirmed by MS on a LCQ Benchtop ESI\MS\MS mass spectrometer (Finnigan Mat, San Jose! , CA, U.S.A.).
Antimicrobial assay
The antimicrobial activity of synthetic peptides and apoA-II was tested as previously described [22] . Briefly, 5i10% colony-forming units (CFU) of mid-exponential-phase cells were incubated for 2 h at 37 mC in 50 µl of PBS [9 mM sodium phosphate (pH 7)\150 mM NaCl] in the presence or absence of the peptides. Thereafter samples were appropriately diluted, plated in duplicate on agar plates and incubated for 20-48 h to determine the number of viable colonies. To test the influence of ionic strength on anti-E. coli activity, cells were also exposed for 2 h to peptide Leu%*-Thr(' (10 µM) or apoA-II (80 µM) in 9 mM sodium phosphate (pH 7) with increasing NaCl concentrations (10-150 mM).
Peptide concentrations were determined by means of quantitative amino acid analysis.
Interaction of peptides with phosphatidylcholine
The association of synthetic peptides with lipids was assessed by monitoring the rate of clearance of the turbidity of Myr # GroPCho multilamellar vesicles (MLV) due to the solubilization of Myr # GroPCho MLV, as described previously [23] . Briefly, a chloroform solution of Myr # GroPCho was transferred to a test tube and the solvent was removed under a stream of N # . The test tube was vortex-mixed to obtain MLV in PBS. The mixture of peptide and Myr # GroPCho MLV was incubated at 25 mC for 10 min and the absorbance was measured spectrophotometrically at 325 nm.
Leakage of liposome contents
The PE\PG\CL (7 : 2 : 1, molar ratio) small unilamellar vesicles (SUV) encapsulating calcein were prepared as described by Lambert et al. [21] . After a 10 min incubation of the peptides with the SUV solution (60 µM phospholipids) at 25 mC in 10 mM Tris\HCl, pH 8, containing 150 mM NaCl and 0.1 g\l Na-EDTA, the release of calcein into the external medium was monitored with a Hitachi F-2000 fluorescence spectrophotometer ; 100 % leakage was achieved by lysis of the vesicles with 5 g\l Triton X-100. The percentage release of calcein was calculated from the following equation :
where b l initial fluorescence, c l total fluorescence observed after addition of Triton X-100 and a l fluorescence at time t.
Electron microscopy
E. coli cells (10) CFU\ml) were incubated with peptide Leu%*-Thr(' (0.2 mg\ml) for different times in PBS at 37 mC. They were fixed with 2.5 % glutaraldehyde\0.1 M cacodylate buffer, pH 7.4, and post-fixed in 1 % OsO % . The cells were embedded in Spurr, (an epoxy resin produced by TAAB Laboratory Equipment Limited, Aldermaston, Berks., U.K.), stained with uranyl acetate and lead citrate and examined under a Hitachi electron microscope (H-600).
CD measurements
CD spectra of the peptides were recorded with a J-600 automatic recording dichrograph (JASCO) at room temperature. Far-UV CD spectra were measured between 200 and 250 nm in a 1-mmoptical-pathlength cuvette at a peptide concentration of 0.2 mg\ml either in a 10 mM sodium phosphate buffer, pH 7.4, or in a 1 : 1 (v\v) mixture of trifluoroethanol (TFE) and buffer. TFE was used as a structure-promoting solvent. CD spectra were also measured in the presence of phospholipid vesicles [peptide\ lipid (P\L) molar ratio 1 : 30]. The phospholipid vesicles were prepared by sonication of Myr # GroPCho or PE\PG\CL MLV, as described previously [24] . CD data are expressed in terms of mean residue ellipticity at 222 nm ([θ] ### ). The helicity was estimated by the equation :
Percentage α-helix l ok([θ] ### j2340)\30300qi100 [25] .
RESULTS

Identification of antimicrobial domain of bovine apoA-II
Purified apoA-II affected the viability of the Gram-negative bacterium E. coli and the yeasts S. cere isiae and Candida albicans [1] . To determine the active site of apoA-II, peptide fragments covering various regions of apoA-II were synthesized ( Figure 1) and their antimicrobial activities were tested. Among them, peptide Leu%*-Thr(' showed significant antimicrobial activity against E. coli (Figure 2a The effect of NaCl on anti-(E. coli) activity of both peptide Leu%*-Thr(' and apoA-II was similar (Figure 2b ), suggesting that peptide Leu%*-Thr(' is responsible for the anti-(E. coli) activity of apoA-II. Since peptide Thr&)-Thr(' does not show anti-(E. coli) activity, residues Leu%*-Gly&( are thought to play an important role for the activity. To assess the role of residues Leu%*-Gly&(, CD spectra of peptide Leu 49 -Thr 76 were determined in 10 mM sodium phosphate at pH 7.4 (spectrum 1), with Myr 2 GroPCho vesicles (spectrum 2), with PE/PG/CL vesicles (spectrum 3) and in 50 % TFE (spectrum 4) as described in the Experimental section. 
Figure 5 Analyses of E. coli viability and protein composition
(a) Exponentially growing cells (10 8 CFU/ml) were incubated with 0.2 mg/ml of the peptides in PBS at 37 mC. At the indicated time, cell suspensions were assessed for viability as described in the Experimental section. Data shown are for peptides Leu 49 Ser) (>). (b) After assays for (a), the rest of samples were centrifuged and proteins from cells (P) and supernatant (S), which had been incubated with peptide Leu 49 -Thr 76 for 15 min (lanes 1 and 2), 30 min (lanes 3 and 4), and 60 min (lanes 5 and 6) or without peptide for 60 min (lanes 7 and 8), were analysed by SDS/PAGE.
peptide Leu%*-Thr(' analogues, peptides Leu%*-Thr('(Phe&# ,&$ Ala) and (Lys&% ,&& Ser) were synthesized ( Figure 1 ). The two peptides did not show any anti-(E. coli) activity at concentrations up to 100 µM (results not shown). These results suggest that residues Leu%*-Gly&( are important in the anti-(E. coli) activity of apoA-II.
Lipid-binding properties of peptides
Previous studies have indicated that the C-terminal region of human apoA-II (residues Thr&!-Gln(() binds phosphatidylcholine (PC) [26] , which is the major lipid of HDL [27] . Therefore, we tested whether peptide Leu%*-Thr(' shows this activity. The formation of complexes between the peptides and PC was monitored by measuring the turbidity of Myr # GroPCho multilamellar vesicles (MLV) with increasing peptides. The apolipoprotein and many synthetic amphipathic peptides were shown to spontaneously form small particles in the size range of HDL, when exposed to PC dispersions [28] . Among the peptides tested, peptides Leu%*-Thr(' and Leu%*-Thr('(Lys&% ,&& Ser), had high lipid-binding activity similar to apoA-II (0.03-0.04 P\L molar ratio), whereas peptide Leu%*-Thr('(Phe&# ,&$ Ala) showed low activity (Figure 3a ). Other peptides, Glu"-Lys$!, Thr&)-Thr(' and Gly$"-Leu'! had very low activity, dissolving MLV at 0.36, 0.41 and 1 (P\L molar ratio) respectively (results not shown). These data suggest that residues Leu%*-Thr(', especially Phe&#-Phe&$, play an important role in the interaction of apoA-II with HDL. As in human apoA-II, Leu&#-Ile&$ has been shown to be important in PC binding [26] .
Since peptide Leu%*-Thr(' binds PC liposomes, it may interact directly with phospholipids in E. coli membranes. To test this possibility, small unilamellar vesicles (SUV) trapping calcein were prepared from a mixture of PE, PG and CL in a molar ratio of 7 : 2 : 1, resembling E. coli membranes [29] , and tested for susceptibility to the peptides (Figure 3b ). Peptide Leu%*-Thr(' and Leu%*-Thr('(Phe&# ,&$ Ala) released calcein from SUV more effectively than did peptide Leu%*-Thr('(Lys&% ,&& Ser). Also these peptides could dissolve PE\PG\CL MLV at nearly the same P\L molar ratio (results not shown). These results suggest that Lys&%-Lys&&, but not Phe&#-Phe&$, are important in membrane destabilization causing the release of contents, although both Phe&#-Phe&$ and Lys&%-Lys&& function in the interaction of peptide Leu%*-Thr(' with membrane phospholipids.
Conformation of synthetic peptides
The secondary structures of the peptides were determined by CD spectroscopy. The α-helicity of peptide Leu%*-Thr(' was increased from 3.5 to 29 and to 36 % by the addition of a Myr # GroPCho and PE\PG\CL vesicles respectively, whereas those of peptides Gly$"-Leu'! and Thr&)-Thr(' were not changed ( Figure 4 and Table 1 ). This is in a good agreement with a previous report that the α-helicity of human apoA-II (residues Thr&!-Gln(() was increased from 17 to 41 % when the peptide was associated with lipid [26] . The α-helix formation in peptide Leu%*-Thr(' is predictable at residues Leu%*-Ala&' by Chou-Fasman analysis [30] and at Leu%*-Lys&& and Leu'!-Phe'% by the GOR (Garnier\ Osguthorpe\Robson) method [31] . It is likely peptide Leu%*-Thr(' can form α-helices at its N-terminal region. The helical content of peptide Leu%*-Thr(' (Lys&% ,&& Ser) was lower than that of peptide Leu%*-Thr(' (Table 1) , probably because Ser tends to form β-turns, whereas Lys promotes helical formation [30] .
Analyses of proteins released by synthetic peptides from E. coli
When E. coli cells were treated with peptide Leu%*-Thr(', the cells were not lysed, as the cell number of the mixture was unchanged during the incubation (results not shown), but lost their proteins into the medium as determined by SDS\PAGE (Figure 5b ). The proteins were recovered from the supernatant of the mixture and had molecular masses of 85, 71, 58, 50, 48 and 16 kDa ( Figure  5b, lanes 2, 4 and 6 ). Peptide Leu%*-Thr('(Phe&# ,&$ Ala), but not peptide Leu%*-Thr('(Lys&% ,&& Ser), showed protein-releasing activity similar to peptide Leu%*-Thr(' (results not shown). However E. coli cells treated with peptide Leu%*-Thr('(Phe&# ,&$ Ala) did not lose their proliferative activity during the incubation (Figure 5a ), although they formed very small colonies on Luria broth\agar plates, compared with those treated with peptide Leu%*-Thr('(Lys&% ,&& Ser) or PBS (results not shown). Thus protein-releasing activity did not correlate well with anti-E. coli activity, though it did cause recoverable damage to the target E. coli cells.
Ultrastructural changes of E. coli cells
We tested the morphological effects of these peptides on the target E. coli cells. Peptide Leu%*-Thr(' caused some drastic effects on the ultrastructure of E. coli cells (Figure 6 ). After a 30 min exposure of cells to the peptide, filamentous structures on the cell surface, which might be pili (fimbriae, fibrillae) [32, 33] , were completely removed, and electron-light nucleoids, which are normally scattered throughout the cytoplasm (Figure 6a) , were gathered together to form clear clusters containing fine fibrillar materials (Figures 6b and 6c) . The cytoplasm was packed together, increasing electron density (Figures 6b and 6c) . These structural changes were confirmed by the electron micrographs taken at a higher magnification (compare Figure 6f with Figure  6e ). At this stage many cells lost proliferative activity (Figure 5a) . At 60 min, the nucleoids were enlarged, becoming electron-lucid by the loss of fibrillar materials. In contrast, the cytoplasm was extensively granulated and was compressed between the nucleoid and the outer membrane. The cytoplasmic membrane was Figure 6d ). These data suggest that the cytoplasmic changes leading to compression of the cytoplasm found only in cells treated with peptide Leu%*-Thr(' (Figure 6c ), rather than changes of the nucleoid, are important to anti-(E. coli) activity as the activity was lost with peptide Leu%*-Thr(' analogues, but not with peptide Leu%*-Thr(' (Figure 5a ).
DISCUSSION
We determined the antimicrobial domain of apoA-II using synthetic peptides, and showed that peptide Leu%*-Thr(' is resposible for anti-(E. coli) activity of apoA-II and that Phe&#-Phe&$-Lys&%-Lys&& is required for the activity.
As described in the Introduction, the target of antimicrobial peptides is often cytoplasmic membrane [12, 14, 17] . However, our present data suggest that peptide Leu%*-Thr(' primarily targets the cytoplasm rather than the membrane of E. coli cells. The evidence supporting this conclusion is as follows.
(a) Amino acid substitutions Phe&# ,&$ Ala in peptide Leu%*-Thr(' diminished its anti-(E. coli) activity, though it failed to affect its membrane-destabilizing activity. In peptide Leu%*-Thr(', the membrane-destabilizing activity did not correlate well with the anti-E. coli activity. Figure 6c ). However, it remains to be clarified whether the ultrastructural consequences result from a triggering of a cellular stress response.
(c) Additionally, electron micrographs of bacteria treated with membrane-acting antimicrobial peptides such as polymyxin [34] [35] [36] , sarcotoxin I [37] , defensins [38] [39] [40] and platelet microbicidal protein [41] show blebbing of the outer membrane or damage of the cytoplasmic membrane. But no blebs on the outer membrane were seen in a cell treated with peptide Leu%*-Thr(' (Figure 6f) . Therefore it appears that the cytoplasmic changes leading to compression of the cytoplasm are important in cell death induced by peptide Leu%*-Thr(' , although the mechanism of what happened in the cytoplasm has not been defined.
The origin of proteins released from E. coli with peptide Leu%*-Thr(' was not clarified in the present study, but it is unlikely that they leaked from the cytosol of E. coli cells, as cytosolic β-galactosidase (EC.3.2.1.23) activity was not detected (results not shown). Electron-microscopic studies showed that filamentous structures on the E. coli cell surface were mostly removed after the treatment with peptide Leu%*-Thr(' for 30 min (compare Figure 6c with Figure 6a ). Although the structures were not well characterized here, they might be pili (fimbriae, fibrillae), which are usually revealed by scanning electron microscopy [32, 33] . Pili are thread-like protein polymers resistant to dissociation into monomers by various denaturing agents such as SDS, which readily disrupts most protein polymers [32] . Therefore it is likely that most of the released proteins detected by SDS\PAGE originated from the outer membrane and\or periplasm of the target E. coli cells.
CD measurement and secondary-structure prediction suggest that peptide Leu%*-Thr(' forms an α-helix at its N-terminal region, which is important in the lipid-binding and anti-(E. coli) activity. An Edmundson-wheel [41a] representation of peptide Leu%*-Thr(' shows that residues Leu%*-Ala&' can form a cationic amphipathic α-helix. Amphipathic α-helices have been shown to play an important role in protein-lipid and protein-protein interactions [42] . The amphipathic α-helix in peptide Leu%*-Thr(' may be necessary at least for the permeation of the E. coli cell membrane to reach the cytoplasm, since peptide Leu%*-Thr('(Lys&% ,&& Ser) with less helical content failed to cause membrane destabilization and any morphological changes in E. coli cells. The inability of peptide Leu%*-Thr('(Phe&# ,&$ Ala) to cause changes of the cytoplasm suggests that Phe&#-Phe&$ on the hydrophobic face of the amphipathic α-helix are important in the lethal event, namely the changes of cytoplasm induced by peptide Leu%*-Thr('. On the other hand, the importance of positive charges of Lys&%-Lys&& remains unclear. It is known that a broad range of cationic antimicrobial peptides show marked decrease in activity at increasing ionic strength [43] [44] [45] [46] [47] [48] [49] . This phenomenon is generally explained by the shielding of charged groups on the peptide and the membrane, thereby preventing interaction between them [50] . In contrast, the anti-(E. coli) activity of peptide Leu%*-Thr(' was slightly decreased by the addition of NaCl. Therefore the positive charge of Lys&%-Lys&& may play a minor role, at least for the penetration of the E. coli cell membrane.
The present study demonstrates that the target of peptide Leu%*-Thr(' is in the cytoplasm and that Phe&#-Phe&$ and α-helical conformation are the major structural requirements for the anti-(E. coli) activity. Antimicrobial peptides are at an early stage of therapeutic drug development for infectious diseases [15] . Further structure-activity analysis of apoA-II may better contribute to the design of antimicrobial peptides which have novel modes of action.
